ACVR1, a Therapeutic Target of Fibrodysplasia Ossificans Progressiva, is Negatively Regulated by MiR-148a

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2012 Mar 13

PMID 22408438

Citations 23

Authors

Hao Song

Qi Wang

Junge Wen

Shunai Liu

Xuesong Gao

Jun Cheng

Deli Zhang

Affiliations

Soon will be listed here.

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare congenital disorder of skeletal malformations and progressive extraskeletal ossification. There is still no effective treatment for FOP. All FOP individuals harbor conserved point mutations in ACVR1 gene that are thought to cause ACVR1 constitutive activation and activate BMP signal pathway. The constitutively active ACVR1 is also found to be able to cause endothelial-to-mesenchymal transition (EndMT) in endothelial cells, which may cause the formation of FOP lesions. MicroRNAs (miRNAs) play an essential role in regulating cell differentiation. Here, we verified that miR-148a directly targeted the 3' UTR of ACVR1 mRNA by reporter gene assays and mutational analysis at the miRNA binding sites, and inhibited ACVR1 both at the protein level and mRNA level. Further, we verified that miR-148a could inhibit the mRNA expression of the Inhibitor of DNA binding (Id) gene family thereby suppressing the BMP signaling pathway. This study suggests miR-148a is an important mediator of ACVR1, thus offering a new potential target for the development of therapeutic agents against FOP.

Citing Articles

The role of miRNAs as biomarkers in heterotopic ossification.

Xie C, Liu X, Li W, Yao Z, Men H, Li Z EFORT Open Rev. 2024; 9(12):1120-1133.

PMID: 39620561 PMC: 11619732. DOI: 10.1530/EOR-22-0100.

Fibrodysplasia ossificans progressiva: Two case reports.

Yaynishet Y, Salah F, Gebregiorgis B, Mume A, Damtew H, Amare T Radiol Case Rep. 2024; 19(8):2973-2977.

PMID: 38737178 PMC: 11087907. DOI: 10.1016/j.radcr.2024.04.019.

The role of miRNA and lncRNA in heterotopic ossification pathogenesis.

Pulik L, Mierzejewski B, Sibilska A, Grabowska I, Ciemerych M, Legosz P Stem Cell Res Ther. 2022; 13(1):523.

PMID: 36522666 PMC: 9753082. DOI: 10.1186/s13287-022-03213-3.

Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9.

Liang L, Xu W, Shen A, Cen H, Chen Z, Tan L Acta Pharmacol Sin. 2022; 43(11):2946-2955.

PMID: 35388129 PMC: 9622742. DOI: 10.1038/s41401-022-00893-8.

Non-coding RNA in endothelial-to-mesenchymal transition.

Hulshoff M, Del Monte-Nieto G, Kovacic J, Krenning G Cardiovasc Res. 2019; 115(12):1716-1731.

PMID: 31504268 PMC: 6755356. DOI: 10.1093/cvr/cvz211.

References

Wang T, Xu Z . miR-27 promotes osteoblast differentiation by modulating Wnt signaling. Biochem Biophys Res Commun. 2010; 402(2):186-9. DOI: 10.1016/j.bbrc.2010.08.031. View

Gao J, Yang T, Han J, Yan K, Qiu X, Zhou Y . MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow. J Cell Biochem. 2011; 112(7):1844-56. DOI: 10.1002/jcb.23106. View

Guo C, Pan Q, Li D, Sun H, Liu B . miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis. J Hepatol. 2009; 50(4):766-78. DOI: 10.1016/j.jhep.2008.11.025. View

Zhang J, Tu Q, Bonewald L, He X, Stein G, Lian J . Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J Bone Miner Res. 2011; 26(8):1953-63. PMC: 3810406. DOI: 10.1002/jbmr.377. View

Majors A, Boehm C, NITTO H, Midura R, Muschler G . Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res. 1997; 15(4):546-57. DOI: 10.1002/jor.1100150410. View

Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibe B . A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet. 2006; 38(7):813-8. DOI: 10.1038/ng1810. View

Manthey C, Mern D, Gutmann A, Zielinski A, Herz C, Lassmann S . Elevated endogenous expression of the dominant negative basic helix-loop-helix protein ID1 correlates with significant centrosome abnormalities in human tumor cells. BMC Cell Biol. 2010; 11:2. PMC: 2818612. DOI: 10.1186/1471-2121-11-2. View

Du Y, Yip H . Effects of bone morphogenetic protein 2 on Id expression and neuroblastoma cell differentiation. Differentiation. 2009; 79(2):84-92. DOI: 10.1016/j.diff.2009.10.003. View

Kaplan F, Le Merrer M, Glaser D, Pignolo R, Goldsby R, Kitterman J . Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol. 2008; 22(1):191-205. PMC: 2424023. DOI: 10.1016/j.berh.2007.11.007. View

10.

Obayashi S, Tabunoki H, Kim S, Satoh J . Gene expression profiling of human neural progenitor cells following the serum-induced astrocyte differentiation. Cell Mol Neurobiol. 2009; 29(3):423-38. PMC: 11506025. DOI: 10.1007/s10571-008-9338-2. View

11.

Medici D, Shore E, Lounev V, Kaplan F, Kalluri R, Olsen B . Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med. 2010; 16(12):1400-6. PMC: 3209716. DOI: 10.1038/nm.2252. View

12.

Guo S, Peng Z, Yang X, Fan K, Ye H, Li Z . miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells. Int J Biol Sci. 2011; 7(5):567-74. PMC: 3088878. DOI: 10.7150/ijbs.7.567. View

13.

Zhang J, Fu W, He M, Xie W, Lv Q, Wan G . MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol. 2011; 8(5):829-38. DOI: 10.4161/rna.8.5.16043. View

14.

Friedman R, Farh K, Burge C, Bartel D . Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2008; 19(1):92-105. PMC: 2612969. DOI: 10.1101/gr.082701.108. View

15.

John B, Enright A, Aravin A, Tuschl T, Sander C, Marks D . Human MicroRNA targets. PLoS Biol. 2004; 2(11):e363. PMC: 521178. DOI: 10.1371/journal.pbio.0020363. View

16.

Lee D, Cho T, Lee H, Park M, Yoo W, Chung C . ACVR1 gene mutation in sporadic Korean patients with fibrodysplasia ossificans progressiva. J Korean Med Sci. 2009; 24(3):433-7. PMC: 2698188. DOI: 10.3346/jkms.2009.24.3.433. View

17.

Bocciardi R, Bordo D, Di Duca M, Di Rocco M, Ravazzolo R . Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements. Eur J Hum Genet. 2008; 17(3):311-8. PMC: 2986177. DOI: 10.1038/ejhg.2008.178. View

18.

Chen Y, Zhu X, Zhang X, Liu B, Huang L . Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol Ther. 2010; 18(9):1650-6. PMC: 2956922. DOI: 10.1038/mt.2010.136. View

19.

Goff L, Boucher S, Ricupero C, Fenstermacher S, Swerdel M, Chase L . Differentiating human multipotent mesenchymal stromal cells regulate microRNAs: prediction of microRNA regulation by PDGF during osteogenesis. Exp Hematol. 2008; 36(10):1354-1369. PMC: 2782644. DOI: 10.1016/j.exphem.2008.05.004. View

20.

Cheng Y, Liu X, Yang J, Lin Y, Xu D, Lu Q . MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res. 2009; 105(2):158-66. PMC: 2728297. DOI: 10.1161/CIRCRESAHA.109.197517. View